DealForma
DealForma is a subscription SaaS platform that provides curated biopharma deal intelligence — covering licensing, M&A, venture funding, and company profiles — to business development, licensing, and corporate development teams at pharmaceutical, biotech, investment, and advisory firms.
- Company typePrivate
- Founded2014
- HeadquartersSan Mateo, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What DealForma does
DealForma is a subscription-based SaaS platform providing curated biopharma deal intelligence to business development, licensing, and corporate development teams at pharmaceutical, biotechnology, investment banking, venture capital, and advisory firms. The company maintains a database covering thousands of biopharma companies, licensing deals, M&A transactions, venture funding rounds, drug pipelines, and drug sales figures, with all profiles and records manually curated and quality-checked by analysts on a daily basis. Source documents — including press releases, SEC-filed contracts, and regulatory filings — are attached to every record, providing provenance that general-purpose databases lack.
The platform is built around three core product modules: (1) the core DealForma database, filterable across stage, modality, therapy area, target, and territory; (2) interactive Tableau dashboards embedded directly in the platform for visualization of decades of deal and funding data; and (3) natural language search that lets users query the database conversationally rather than via complex filter interfaces. Site-licensed enterprise customers additionally gain API/data feed access to pipe DealForma data into internal systems, and all subscribers receive 20 hours per year of dedicated analyst support for custom data pulls, benchmarking, chart creation, and report building. Authentication is handled via Auth0 and subscription billing via Stripe, supporting a global direct-sales motion.
DealForma monetizes exclusively through annual SaaS subscriptions priced at a $18,000-$20,000 minimum starting price, positioning the platform below competing enterprise offerings (PitchBook, BioCentury BCIQ). The go-to-market is direct enterprise field sales with scheduled 30-minute screen-share demos as the primary conversion mechanism, supplemented by content marketing via quarterly deal trend reports, an Endpoints News editorial column, and customer testimonials from named logos including GSK, Novartis, AbbVie, JPMorgan, Nimbus Therapeutics, Flagship Pioneering, and IP Group. The company is privately held and founder-led, headquartered in San Mateo, California, with a small globally distributed team of analysts and developers.
DealForma firmographics
Firmographics- Name
- DealForma
- Legal name
- DealForma, LLC
- Website
- https://dealforma.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DealForma is a subscription SaaS platform that provides curated biopharma deal intelligence — covering licensing, M&A, venture funding, and company profiles — to business development, licensing, and corporate development teams at pharmaceutical, biotech, investment, and advisory firms.
- Ownership category
- akta.pro rank
Where DealForma is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DealForma business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Annual SaaS Subscription: DealForma operates on a subscription model billed annually. Subscriptions include access to the full database, interactive dashboards, natural language search, data export, and bundled analyst support hours. Annual billing cycles with automatic renewal unless cancelled. Valid invoiced payment methods including credit card, wire transfer, check, or purchase order accepted. Fee changes are communicated at least 30 days in advance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Site License / Enterprise (minimum starting price) |
| Subscription | Annual | Site License / Enterprise (minimum starting price) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
DealForma product offering
Product offeringCore offering
DealForma is a cloud-based SaaS biopharma deal intelligence platform that provides curated, analyst-vetted data on licensing deals, M&A transactions, venture funding, company profiles, drug pipelines, and drug sales figures for biotech and pharmaceutical companies. Subscriptions include interactive Tableau dashboards, natural language search, bundled analyst support, data export, and API access for site-licensed enterprise customers.
Product overview
DealForma is a biopharma deal intelligence platform offering a unified database with multiple integrated modules. The core product is the DealForma Core Database, which provides comprehensive coverage of licensing deals, M&A, venture funding, company profiles, drug pipelines, and drug sales figures—all updated daily by analysts. The platform integrates Interactive Tableau Dashboards for data visualization and features Natural Language Search for simplified querying. All subscriptions include Analyst Support with 20 hours per year for custom analyses and benchmarking. Additional modules include Quarterly Deal Trend Reports, Data Export Capability, Data Feed/API for enterprise customers, and Saved Searches and Alerts for deal monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- DealForma Platform The primary biopharma deal intelligence SaaS platform providing meticulously researched licensing deal financial comps, up-to-date company profiles, historic deal and pipeline data, drug sales figures, and curated reports. Data covers biotech, pharma, diagnostics, medtech, and digital health companies. Designed for business development, licensing, and corporate development professionals at biopharma companies and life sciences investors.
- Quarterly Deal Trend Reports Subscription deliverables offering quarterly chart packs of deal trends across therapeutic areas and deal types, designed to be embedded directly into customer presentations. Available to subscribers.
Quantifiable outcome
- Customer testimonial: completed a project in one afternoon that would previously have taken a week or a student a month
- +2 more outcomes
Companies that use DealForma
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles4 records
DealForma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature6 records
DealForma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- TableaucoreDealForma builds its interactive data dashboards using Tableau. This is a core component of the platform's data visualization capability, embedded within the DealForma interface to allow users to customize charts by therapy area, modality, stage, and other filters.
- StripesupportingDealForma uses Stripe as its third-party payment processor for subscription billing. Stripe handles payment card processing and is compliant with PCI-DSS standards set by the PCI Security Standards Council.
- Google AnalyticssupportingDealForma uses Google Analytics to monitor and analyze website traffic and usage of its service.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
DealForma competitors and assessment
Company assessmentBroad incumbents
- PitchBook Data: PitchBook (owned by Morningstar) is the dominant VC, PE, and M&A deal database. It is directly comparable to DealForma for biopharma deal comps but covers many industries; DealForma explicitly positions its curation depth and lower entry price ($18K vs $40K) against PitchBook.
- Cortellis (Clarivate): Cortellis provides life-sciences intelligence including deals, pipelines, and company profiles as part of Clarivate's broader portfolio. Comparable to DealForma's deal-comps and pipeline data with much broader coverage but less biopharma-specific curation.
- GlobalData: GlobalData offers deal databases, company profiles, and market intelligence across pharma and other industries. Comparable as a multi-industry incumbent that competes for similar BD intelligence budgets at large pharma.
- CB Insights: CB Insights provides market intelligence on venture financing, M&A, and emerging technology trends, with coverage that overlaps DealForma's funding-rounds and company-profiles data for biopharma and adjacent verticals.
- Crunchbase: Crunchbase is a broad startup and investment database covering funding rounds, M&A, and company information. It overlaps DealForma's venture-funding and company-profile data, particularly for biotech and digital health startups, though with less biopharma-specific curation.
Direct peers
- BioCentury BCIQ: BCIQ is BioCentury's biopharma deal intelligence platform covering licensing, M&A, and venture financing — the closest direct competitor to DealForma. DealForma's pricing comparison page lists its minimum price at $20K vs BCIQ, indicating head-to-head competition for biopharma BD subscribers.
- Evaluate Pharma: Evaluate Pharma provides consensus forecasts, deal data, and commercial intelligence for the pharma and biotech sector. It directly overlaps DealForma's drug sales figures and company profile offerings, targeting similar enterprise pharma BD users.
Emerging players
- AlphaSense: AlphaSense is a market intelligence platform aggregating broker research, SEC filings, and transcripts for enterprise research workflows. It is listed alongside DealForma among top pharma market intelligence platforms and competes for similar enterprise research budgets with an AI-first search product.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
DealForma social profiles
Digital presenceDealForma financial estimates
Financial estimateRevenue estimate
Valuation estimate
DealForma leadership team
Management profileNumber of profiles
Profiles2 records
DealForma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DealForma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DealForma
What does DealForma do?
DealForma is a cloud-based SaaS biopharma deal intelligence platform that provides curated, analyst-vetted data on licensing deals, M&A transactions, venture funding, company profiles, drug pipelines, and drug sales figures for biotech and pharmaceutical companies. Subscriptions include interactive Tableau dashboards, natural language search, bundled analyst support, data export, and API access for site-licensed enterprise customers.
Is DealForma a public or private company?
DealForma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DealForma founded?
DealForma was founded in 2014. It employs 1 to 10 people.
Where is DealForma based?
DealForma is headquartered in San Mateo, United States, in the North America region.
How does DealForma make money?
One revenue line is on record: annual SaaS Subscription.
Who are DealForma's main competitors?
Broad incumbents on record are PitchBook Data, Cortellis (Clarivate), GlobalData, CB Insights and Crunchbase. Direct peers are BioCentury BCIQ and Evaluate Pharma. AlphaSense is listed as an emerging player.
Does DealForma have an API?
Yes. DealForma offers Data Feed/API capability for Site Licensed customers, allowing them to pipe DealForma data directly into their internal dashboards. The API enables programmatic access to deal data, funding information, company profiles, and drug sales figures.